MaxCyte, Inc.
MXCT
$2.16
-$0.045-2.05%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -14.48% | -6.44% | 19.85% | 11.69% | 6.80% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -14.48% | -6.44% | 19.85% | 11.69% | 6.80% |
| Cost of Revenue | 39.83% | 49.73% | 35.56% | -0.64% | 2.18% |
| Gross Profit | -21.66% | -13.73% | 17.63% | 13.53% | 7.44% |
| SG&A Expenses | -2.78% | -1.21% | 9.80% | 16.04% | 20.73% |
| Depreciation & Amortization | -0.12% | 3.96% | 10.28% | 20.89% | 38.37% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.80% | 0.27% | 8.23% | 12.69% | 17.80% |
| Operating Income | -8.06% | -6.00% | 1.20% | -13.70% | -30.28% |
| Income Before Tax | -14.28% | -8.26% | 4.59% | -8.56% | -20.34% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -14.28% | -8.26% | 4.59% | -8.56% | -20.34% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.28% | -8.26% | 4.59% | -8.56% | -20.34% |
| EBIT | -8.06% | -6.00% | 1.20% | -13.70% | -30.28% |
| EBITDA | -8.92% | -6.24% | 2.17% | -13.09% | -29.72% |
| EPS Basic | -12.34% | -6.53% | 5.97% | -7.14% | -18.72% |
| Normalized Basic EPS | -12.37% | -6.58% | 5.94% | -7.20% | -18.72% |
| EPS Diluted | -12.34% | -6.53% | 5.97% | -7.14% | -18.72% |
| Normalized Diluted EPS | -12.37% | -6.58% | 5.94% | -7.20% | -18.72% |
| Average Basic Shares Outstanding | 1.68% | 1.53% | 1.47% | 1.48% | 1.50% |
| Average Diluted Shares Outstanding | 1.68% | 1.53% | 1.47% | 1.48% | 1.50% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |